Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.
Journal Information
Full Title: Cancer Epidemiol Biomarkers Prev
Abbreviation: Cancer Epidemiol Biomarkers Prev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Evidence found in paper:
"supplementary table s3. raw data"
Code Sharing
COI Disclosure
Evidence found in paper:
"Authors' Disclosures No disclosures were reported."
Funding Disclosure
Evidence found in paper:
"The study was supported by grants from the Italian Association for Cancer Research [AIRC 5xmille IG 12162; Investigator grant nos. 23244 to G. Sozzi, 25078 to V. Huber, Italian Ministry of Health (RF-2018-12367824 to G. Sozzi; GR-2016-02361849 to M. Boeri)]."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025